publication venue for
- Ultrasound-Guided Transfemoral Access for Coronary Procedures: A Pooled Learning Curve Analysis From the FAUST and UNIVERSAL Trials. 17:e013817. 2024
- Single Bolus r-SAK Before Primary PCI for ST-Segment–Elevation Myocardial Infarction. 17:e013455. 2024
- Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial. 16:e012867. 2023
- Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAVR Economic Study. 15:e012168. 2022
- Prognostic Role of Residual Thrombus Burden Following Thrombectomy: Insights From the TOTAL Trial. 15:e011336. 2022
- Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment–Elevation Myocardial Infarction: Insights From the COMPLETE Trial. 14:e010458. 2021
- Radial First in ST-Segment–Elevation Myocardial Infarction. 14:e010595. 2021
- Increasing Wait-Time Mortality for Severe Aortic Stenosis. 13:e009297. 2020
- Nonculprit Lesion Plaque Morphology in Patients With ST-Segment–Elevation Myocardial Infarction. 13:e008768. 2020
- Cardiogenic Shock in the Setting of Acute Myocardial Infarction. 13:e009034. 2020
- Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women. 12:e007086. 2019
- Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel. 12:e007019. 2019
- Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. 11:e007368. 2018
- Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors. 11:e006084. 2018
- Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease. 11:e005795. 2018
- MitraClip and Transcatheter Aortic Valve Replacement in a Patient With Recurrent Heart Failure. 10:e005312. 2017
- Platelet Transfusion for Ticagrelor Reversal. 10:e005579. 2017
- Multivessel Revascularization and ST-Segment–Elevation Myocardial Infarction. 10:e005215. 2017
- Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. 9:e004395. 2016
- Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events. 9:e004336. 2016
- Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis. 9:e003785. 2016
- Optical Coherence Tomography–Guided Percutaneous Coronary Intervention in ST-Segment–Elevation Myocardial Infarction. 9:e003414. 2016
- Randomized Controlled Trial of Radiation Protection With a Patient Lead Shield and a Novel, Nonlead Surgical Cap for Operators Performing Coronary Angiography or Intervention. 8:e002384. 2015
- Reperfusion Times for Radial Versus Femoral Access in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. 8:e002097. 2015
- Activated Clotting Time and Outcomes During Percutaneous Coronary Intervention for Non–ST-Segment–Elevation Myocardial Infarction. 8:e002044. 2015
- Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent. 8:e002372. 2015
- Clinical Outcomes of Treatment by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Patients With Chronic Kidney Disease Undergoing Index Revascularization in Ontario. 8:e001973. 2015
- Mentored Simulation Training Improves Procedural Skills in Cardiac Catheterization. 5:672-679. 2012
- Antithrombotic Therapy After Coronary Artery Stenting in Patients With Atrial Fibrillation. 5:454-455. 2012
- Cardiovascular Devices and Platelet Interactions. 5:296-304. 2012
- Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy. 4:545-552. 2011
- CYP2C19 Genetic Testing Should Not Be Done in All Patients Treated With Clopidogrel Who Are Undergoing Percutaneous Coronary Intervention. 4:514-521. 2011
- Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting. 4:522-534. 2011
- Current Evidence for Genetic Testing in Clopidogrel-Treated Patients Undergoing Coronary Stenting. 4:505-513. 2011
- Characterization of Operator Learning Curve for Transradial Coronary Interventions. 4:336-341. 2011